In the data, we nd that the VVIX. has separate dynamics from the VIX, so that. uctuations in volatility of volatility are not. directly tied to movements in market volatility. The volatility-of-volatility risks are a signif-. icant risk factor which a ects the time-series and the cross-section of index and VIX option.
CONCLUSION: The Meniett device is a minimally invasive, nondestructive treatment that may be used to provide longer-term reduction of vestibular symptoms in patients with Meniere'mÃ©niÃ¨re s. [PubMed-pubmed indexed FOR]. medlineONCLUSION: The Meniett device is a minimally invasive, nondestructive treatment that may be used to provide longer-term reduction of vestibular symptoms in patients with Meniere'mÃ©niÃ¨re s. [PubMed-pubmed indexed FOR]. medline
The NovoTTF-100A System was approved by the U.S. Food and Drug Administration in April 2011, as a novel device to treat adults with glioblastoma multiforme (GBM) that recurs or progresses after receiving chemotherapy and radiation therapy.escription/Scope. This document addresses electrical fields known as tumor treatment fields (TTF) that are created by low-intensity, intermediate frequency (100â200 kilohertz [kHz]) electric currents delivered to the malignant tumor site by insulated electrodes placed on the skin surface.